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As personal genetic information be-
comes an increasingly frequent component
of the patient medical record, it is crucial
that medical students be trained to use and
interpret this information appropriately
and responsibly. Here, I argue the need
for medical education reform that equips
physicians with the knowledge, skills, and
attitudes required to practice personalized
medicine.
The Era of Personalized
Medicine
The sequencing of the human genome,
followed by the related HapMap project,
and the explosive number of genome-wide
association studies conducted over the last
decade, have heralded a new era of
medicine. The vision of a personalized medicine,
where a patient’s personal genetic and
environmental information is used collec-
tively to predict individual risks of disease
and responsiveness to drugs, promises to
revolutionize the medical management of
many illnesses. Physicians have long used
environmental factors like diet and exercise
in preventative health and treatment strat-
egies; however, despite being championed
by genome scientists and those in the
biotechnology industry, personalized medi-
cine hasyet to be adopted by most clinicians.
It has, however, already reached a growing
number of consumers, who are helping to
usher in this new era as they arrive at their
doctor’s office with their personal genetic
code and a long list of questions in hand.
Since 2007, three companies (Navi-
genics in Redwood Shores, California,
deCODE Genetics of Reykjavik, Iceland,
and 23andMe in Mountain View, Cali-
fornia) have each been offering direct-to-
consumer, whole-genome testing for
markers thought to be predictive of traits
and disorders ranging from the ability to
roll your tongue to chronic diseases like
cancer and coronary artery disease. To do
these tests, the companies examine the
DNA from a customer’s saliva sample (via
a convenient mail-in kit) at up to a million
of the sites of genetic variation known as
single nucleotide polymorphisms. The
customer is delivered an individualized
report of predicted health risks, based on
aggregate data from hundreds of single-
gene and genome-wide association studies
on various traits and diseases. Many
customers are apparently satisfied with
the services they receive. However, a
dilemma precipitates when customers face
ambiguous or alarming results needing
expert interpretation, and they heed the
timeless suggestion: ask your health care
provider for more information.
Data suggest that when faced with such a
dilemma, the American public will turn to
their primary care providers (PCPs). In one
study of 1,000 individuals living in the
United States, 72% of respondents indicated
that they would ask their PCP if they had a
question about genetics [1]. Indeed, based
on personal experience at Stanford Univer-
sity Hospital & Clinics, situated at the nexus
of the genomics revolution in Silicon Valley,
patients have already begun to arrive at their
physician’s office with 23andMe reports in
hand seeking expert medical advice. While
some physicians are equipped to interpret
such reports, evidence indicates that the
majority of physicians are poorly prepared
to deal with issues related to genetics and
genomics, and that such patients arelikely to
be disappointed and misinformed [2–4]. In
one survey of 5,915 individuals and families
with genetic conditions, 64% of respondents
reported receiving no genetics education
materials from the health care provider they
named most important in the management
of their condition [4]. Another study showed
that one-third of physicians incorrectly
interpreted the results of a single-gene test
for colorectal cancer susceptibility [5]. Even
educational material mailed to practicing
physicians by a genetic testing company
proved ineffective in one study, where each
basic question about genetic testing was
answered incorrectly by over half of physi-
cians, irrespective of receipt of the educa-
tional mailer [6]. This suggests more formal
and fundamental training is required to
enhance physicians’ knowledge about ge-
netics and genetic testing, and their ability to
provide effective genetic counseling; indeed,
68% of physicians in the study reported an
increased need or desire to learn more about
genetics and genetic testing. Finally, physi-
cians often fail to elicit detailed or updated
family histories on their patients, an omis-
sion several studies have found to hinder the
effective use of genetic testing and genetic
counseling [7,8]. Together, these studies
s u g g e s tt h a tm a n yp h y s i c i a n sa r en o t
adequately trained to appropriately order,
or interpret and communicate results from
even single-gene tests, let alone tests incor-
porating the full genome.
Harnessing the potential power of
genomics in medicine requires physicians
who can effectively use genetic tests and
critically evaluate and interpret their
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reflects the lack of sufficient education in
genetics and genomics throughout medical
training. As genetic components underlie
disorders in nearly all medical domains,
and patients most often turn to their PCP
for questions about genetic testing [1], all
medical trainees should be well-versed in
the basic principles of genetics and geno-
mics. Moreover, with only 3,300 genetics
professionals in the United States who are
certified by the American Board of
Medical Genetics and/or the American
Board of Genetic Counseling [9], PCPs
will be increasingly relied upon to perform
genetic counseling and risk assessment.
Without appropriate revisions in clinician
training, the supply of genomics-savvy
physicians could be markedly outstripped
by a rapidly increasing demand.
Closing the Gap in Medical
Education
The genetics education that physicians-in-
training typically receive in medical school
and graduate medical education is ill-suited
for practicing personalized medicine. Med-
ical schoolsshould improve their curricula to
include not only more basic science concepts
in genetics and genomics, but also practical
training for their applications in clinical
medicine. Unfortunately, in a recent study
only 11% of US and Canadian medical
schools reported practical training in the use
of medical genetics as part of their curricula
[10]. A natural starting place to instill the
essential core competencies is the first-year
medical school curriculum.
For example, the most basic skill with
which every medical student should be
invested is how to take a ‘‘genetic histo-
ry’’—that is, a family history of adequate
detail and accuracy to assess genetic risk.
Coupled with this requirement, every
medical student should also learn how to
synthesize this information to determine
the clinical contexts where genetic/geno-
mictesting orreferraltoa geneticcounselor
is warranted. To achieve these learning
objectives, medical schools should strive to
teach genetics and genomics beyond the
scope of a stand-alone basic science course.
Genetics should be incorporated into a
‘‘Practice of Medicine’’ or equivalent
course, where medical students learn how
to conduct the patient interview and
physical examination. Equally important,
improved education is needed to enable
medical trainees to interpret the results of
genetic tests in a clinical setting.
To further prepare for the dawning era of
personalized medicine,medical studentsmust
learn the principles of genetic variation in the
human population and how genome-wide
studies of complex diseases are conducted
and analyzed. Notably, the same principles
from simple Mendelian genetics cannot be
applied to the genomics of complex diseases
(e.g., diabetes, cancer, asthma, and heart
disease). Genome-wide association studies
often find genetic variants that contribute
very little to overall risk for disease and are
statistically determined at a population level,
which can be misleading when applied
directly to an individual. For example, a
man who learns he has a low-risk genetic
variant for heart disease (e.g., a single
nucleotide polymorphism with an odds ratio
of 0.90, or a decreased risk of 10%) should
not in turn disrupt his exercise or diet
regimen, as the protective genetic effect
may be easily offset by the deleterious effect
of an unhealthy lifestyle. If the variant is
common in the population, its effect may be
statistically significant at the population level,
but not clinically significant for an individual
patient. The reverse may hold in other cases,
where genetic risk trumps environmental
risks. For example, a patient harboring a
variant of the APOE gene has anywhere
b e t w e e na6 - f o l da n d3 3 - f o l di n c r e a s e dr i s ko f
developing Alzheimer disease, depending on
the individual’s race [11]. Genetic variation
in the population also underlies patient-to-
patient differences in drug response. Under-
scoring the importance of pharmacogenetics
to clinical practice, the US Food and Drug
Administration has recently modified the
label for drugs such as warfarin and
clopidogrel (Plavix) to warn that genetic
variants present in a patient may warrant
careful assessment of whether to use the drug
a n dw h a td o s et ou s e .F i n a l l y ,f o rm a n y
complex disorders new risk-modulating ge-
netic variants, and their interactions with
each other and with environmental factors,
continue to be discovered on an ongoing
basis. Thus, medical students must be taught
how genetic factors for disease and drug
response are determined, how they are
modified by other factors, and how to
interpret the significance of test results in
the context of an individual patient with a
specific medical profile.
Several national organizations are call-
ing for improved genetics education
among health professionals. To help drive
and coordinate this effort in the United
Kingdom, the National Genetics Educa-
tion and Development Centre (http://
www.geneticseducation.nhs.uk/) has de-
veloped evidence-based learning objectives
and competencies in genetics for health
professionals [12]. In the United States,
the National Coalition for Health Profes-
sional Education in Genetics (NCHPEG;
http://www.nchpeg.org/) has also identi-
fied a set of core competencies in genetics
that all health professionals should possess.
The strategies offered by these organiza-
tions for improving genetics education will
serve as a strong starting place for medical
school and graduate medical education
reform.
Conclusion
As genetic and genomic health informa-
tion become routine components of pa-
tients’health records, we must asphysicians
become facile with the use and interpreta-
tion of this information as early as possible
in our careers. Fundamental training in
genetics and genomics, along with the
attendant medical, legal, ethical, and psy-
chosocial issues, should fall within the
purview of medical school education.
Moreover, such education should continue
longitudinally throughout clinical training,
including residency, fellowship, and con-
tinuing medical education programs, to
reinforce concepts and target physicians
who have already completed their clinical
training. The potential of genetics and
genomics to provide new paradigms for
prevention, diagnosis, and treatment of
disease is immense, but before the vision
of a personalized medicine can be fully
realized, medical trainees must be given the
proper educational foundation.
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